RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to DHFR

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
METHOTREXATE	Small molecule	immune system disease	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	Granulomatosis with Polyangiitis	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	Ectopic pregnancy	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	peritoneum cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	systemic lupus erythematosus	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	prostate cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	mixed phenotype acute leukemia	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	head and neck squamous cell carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED TROMETHAMINE	Small molecule	large cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	Pure red cell aplasia	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	peritoneum cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	brain neoplasm	Dihydrofolate reductase inhibitor	0.5	Completed	ClinicalTrials
METHOTREXATE	Small molecule	ankylosing spondylitis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	Biphasic Mesothelioma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	temporal arteritis	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	polyarticular arthritis	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	carcinoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	ankylosing spondylitis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	childhood acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED DISODIUM	Small molecule	renal pelvis/ureter urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic syndrome	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE SODIUM	Small molecule	drug interaction	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Mantle cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED DISODIUM	Small molecule	peritoneum cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Enrolling by invitation	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	asthma	Dihydrofolate reductase inhibitor	3.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastatic malignant neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	Thymic Carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	osteopetrosis	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	Sezary's disease	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	temporal arteritis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	childhood acute myeloid leukemia with maturation	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	multiple myeloma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Crohn's disease	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	adult T-cell leukemia/lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	leptomeningeal metastasis	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	colorectal carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	T-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	non-melanoma skin carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic syndrome	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PRALATREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	chronic myelogenous leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Crohn's disease	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	osteosarcoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	myeloproliferative disorder	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis vulgaris	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	gastric cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	T-lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PEMETREXED TROMETHAMINE	Small molecule	adenocarcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED DISODIUM	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	chronic myelomonocytic leukemia	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	thyroid cancer	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	congenital amegakaryocytic thrombocytopenia	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	esophageal carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	pain	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	chronic lymphocytic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Crohn's disease	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Vitiligo	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	Thymoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	mucopolysaccharidosis type 2	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	arthritis	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	Juvenile Myelomonocytic Leukemia	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	osteoarthritis	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	renal pelvis/ureter urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myelofibrosis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	medulloblastoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	gout	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	anterior uveitis	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Takayasu arteritis	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	colorectal carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic syndrome	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	ulcerative colitis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Polyarteritis Nodosa	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	childhood ependymoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	osteosarcoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	juvenile idiopathic arthritis	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	retinitis pigmentosa	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastatic malignant neoplasm	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	primary biliary cirrhosis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	biliary tract cancer	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	osteoarthritis	Dihydrofolate reductase inhibitor	3.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Glycogen storage disease due to acid maltase deficiency	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	atopic eczema	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	polycythemia vera	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	Biphasic Mesothelioma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	childhood acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	brain cancer	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	cutaneous melanoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	squamous cell carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED	Small molecule	thymus cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	choriocarcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	myocardial infarction	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	upper aerodigestive tract neoplasm	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PRALATREXATE	Small molecule	T-cell non-Hodgkin lymphoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	gestational trophoblastic neoplasm	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	pancreatic neoplasm	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Langerhans Cell Histiocytosis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-Hodgkins lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	rectum cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Shwachman-Diamond syndrome	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	endometrial cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	refractory anemia with ringed sideroblasts	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	proliferative vitreoretinopathy	Dihydrofolate reductase inhibitor	1.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Aplastic anemia	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	adult acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	0.5	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	cervical cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	extranodal nasal NK/T cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	gestational trophoblastic neoplasm	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PIRITREXIM	Small molecule	renal pelvis/ureter urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	neuroblastoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Suspended	ClinicalTrials
METHOTREXATE	Small molecule	psoriatic arthritis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	colorectal carcinoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	peritoneum cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	0.5	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	Thymoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Fanconi anemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Burkitts lymphoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	B-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	Uveal Melanoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	childhood B acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	salivary gland carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PRALATREXATE	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	4.0	-	ATC
METHOTREXATE	Small molecule	colorectal cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	cervical cancer	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	esophageal cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	sickle cell anemia	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	gestational trophoblastic neoplasm	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	Cutaneous T-cell lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	colorectal neoplasm	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	childhood B acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	osteoarthritis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	urethra cancer	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	angioimmunoblastic T-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Langerhans Cell Histiocytosis	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	head and neck squamous cell carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	psoriatic arthritis	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Vitiligo	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	non-Hodgkins lymphoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	Lymphoma, AIDS-Related	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	osteoarthritis	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	renal pelvis/ureter urothelial carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute promyelocytic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	mycosis fungoides	Dihydrofolate reductase inhibitor	4.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	uveitis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	multiple sclerosis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell squamous lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	Burkitts lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	stomach neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	stricture	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	head and neck squamous cell carcinoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PRALATREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	childhood T acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	blastic plasmacytoid dendritic cell neoplasm	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	precursor T-cell lymphoblastic leukemia-lymphoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	childhood T acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	salivary gland carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	renal pelvis/ureter urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	neoplasm of mature B-cells	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	colorectal neoplasm	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	primary peritoneal carcinoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	central serous retinopathy	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	Thymic Carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Ectopic pregnancy	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PRALATREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	squamous cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myeloid neoplasm	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	refractory anemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	metastasis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	neuroendocrine neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	COVID-19	Dihydrofolate reductase inhibitor	1.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	male breast carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	microscopic polyangiitis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	adult acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	juvenile idiopathic arthritis	Dihydrofolate reductase inhibitor	0.5	Completed	ClinicalTrials
METHOTREXATE	Small molecule	bullous pemphigoid	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Desmoid-type fibromatosis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	mycosis fungoides	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	temporal arteritis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	post-transplant lymphoproliferative disease	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute leukemia of ambiguous lineage	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastatic malignant neoplasm	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	neuroblastoma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	myeloproliferative disorder	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PRALATREXATE	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	breast neoplasm	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	childhood T acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	myocardial infarction	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	1.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	adenosquamous lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	medulloblastoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	adult T acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PRALATREXATE	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	IgG4-related retroperitoneal fibrosis	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
PRALATREXATE	Small molecule	adult T-cell leukemia/lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	hematopoietic and lymphoid cell neoplasm	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE SODIUM	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PRALATREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PRALATREXATE	Small molecule	Cutaneous T-cell lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PIRITREXIM	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	renal cell carcinoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	primary myelofibrosis	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	anaplastic large cell lymphoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	head and neck squamous cell carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	carcinoma	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	childhood acute myeloid leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	anaplastic large cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	urticaria	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	sensorineural hearing loss	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	chronic lymphocytic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	stomach neoplasm	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	non-Hodgkins lymphoma	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis vulgaris	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	bone marrow failure syndrome	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	follicular lymphoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	chronic myeloproliferative disorder	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute graft vs. host disease	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	extranodal nasal NK/T cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	dermatomyositis	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	squamous cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast neoplasm	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	chronic myelogenous leukemia	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	peritoneum cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Hodgkins lymphoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	brain neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	schizophrenia	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	multiple sclerosis	Dihydrofolate reductase inhibitor	0.5	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	bronchoalveolar adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	adult acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic syndrome	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	juvenile idiopathic arthritis	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	medulloblastoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	psoriatic arthritis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	Fallopian Tube Carcinoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	Merkel cell skin cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urethra cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic/myeloproliferative disease	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urogenital neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Granulomatosis with Polyangiitis	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Mantle cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Glycogen storage disease due to acid maltase deficiency	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Splenic Marginal Zone Lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	ankylosing spondylitis	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Dihydrofolate reductase inhibitor	3.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic syndrome	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	cardiovascular disease	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	alopecia areata	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	rectum cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	gastric cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant glioma	Dihydrofolate reductase inhibitor	0.5	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	adenosquamous lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	mixed phenotype acute leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	osteosarcoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PRALATREXATE	Small molecule	multiple myeloma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	gout	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoid leukemia	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	metastatic malignant neoplasm	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	adult B acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	T-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	choriocarcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	Wiskott-Aldrich syndrome	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Enrolling by invitation	ClinicalTrials
METHOTREXATE	Small molecule	non-Hodgkins lymphoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	extranodal nasal NK/T cell lymphoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	refractory anemia with excess blasts	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	colorectal carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Suspended	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	Myasthenia gravis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	pregnancy	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	systemic lupus erythematosus	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	ovarian carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	colorectal neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	prostate cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	severe aplastic anemia	Dihydrofolate reductase inhibitor	3.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Juvenile Myelomonocytic Leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	childhood acute myeloid leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	B-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastatic colorectal cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder carcinoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	colorectal carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriatic arthritis	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myelofibrosis	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	primary myelofibrosis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	hairy cell leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	multiple sclerosis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	sarcoidosis	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute erythroleukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	breast carcinoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	osteosarcoma	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Suspended	ClinicalTrials
METHOTREXATE	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	T-cell large granular lymphocyte leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	3.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	metastasis	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	childhood B acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	fallopian tube cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	non-infectious posterior uveitis	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PRALATREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	pancreatic carcinoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PRALATREXATE	Small molecule	Sezary's disease	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	colorectal adenocarcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	vasculitis	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	childhood acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	Diamond-Blackfan anemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	renal pelvis/ureter urothelial carcinoma	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	MALT lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	3.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant peritoneal mesothelioma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	hematopoietic and lymphoid cell neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	metastasis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	ankylosing spondylitis	Dihydrofolate reductase inhibitor	4.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	fallopian tube cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic syndrome	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	juvenile idiopathic arthritis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	1.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	Myelodysplastic/Myeloproliferative Neoplasm	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	leptomeningeal metastasis	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	anaplastic large cell lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Neoplasm	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	temporal arteritis	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	squamous cell carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	squamous cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Waldenstrom macroglobulinemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Ectopic pregnancy	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	esophageal cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	endometrial cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PRALATREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	fallopian tube cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	severe combined immunodeficiency	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute monocytic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriatic arthritis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Neoplasm	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urethra cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	3.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	fungal infectious disease	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	urinary bladder carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	3.0	Enrolling by invitation	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	choroid plexus neoplasm	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	neurofibromatosis type 1	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	breast neoplasm	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PRALATREXATE	Small molecule	bladder transitional cell carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	drug interaction	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	T-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	beta-thalassemia major	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	bone sarcoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	Crohn's disease	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	metastatic colorectal cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	chronic myelomonocytic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	childhood B acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urogenital neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	leptomeningeal metastasis	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED DISODIUM	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	anaplastic large cell lymphoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	uveitis	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	sarcoidosis	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	paroxysmal nocturnal hemoglobinuria	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PRALATREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	3.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	meningeal neoplasm	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	bladder transitional cell carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	urethra cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	large cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	plasma cell leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	adult acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	cutaneous melanoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	4.0	-	ATC
METHOTREXATE	Small molecule	glycogen storage disease II	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	chronic myeloproliferative disorder	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PRALATREXATE	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute myelomonocytic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriatic arthritis	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	inflammation	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	4.0	-	FDA
PEMETREXED DISODIUM	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	head and neck carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	3.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	immune system disease	Dihydrofolate reductase inhibitor	4.0	-	ATC
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	3.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PRALATREXATE	Small molecule	peritoneum cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	myelofibrosis	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	kidney cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	adult acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	proliferative vitreoretinopathy	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	colorectal carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	head and neck squamous cell carcinoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	upper aerodigestive tract neoplasm	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	systemic lupus erythematosus	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	polyarticular arthritis	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	colorectal adenocarcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	0.5	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	brain neoplasm	Dihydrofolate reductase inhibitor	0.5	Recruiting	ClinicalTrials
PIRITREXIM	Small molecule	urethra cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	endometrial cancer	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	hematopoietic and lymphoid cell neoplasm	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	hematopoietic and lymphoid cell neoplasm	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	juvenile idiopathic arthritis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	metastatic melanoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PRALATREXATE	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	childhood acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	follicular lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastasis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	mycosis fungoides	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	adult B acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urinary bladder cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	adenocarcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	extranodal nasal NK/T cell lymphoma	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	coronary artery disease	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	atopic eczema	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	childhood T acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Central Nervous System Lymphoma	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	breast carcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	nasopharyngeal neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	osteoarthritis, hand	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
PRALATREXATE	Small molecule	mycosis fungoides	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	acute promyelocytic leukemia	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Vitiligo	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PRALATREXATE	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	Thymoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	liver cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	gastric carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	renal cell carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PRALATREXATE	Small molecule	breast carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	hemophagocytic syndrome	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Crohn's disease	Dihydrofolate reductase inhibitor	4.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	malignant pleural mesothelioma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	pancreatic carcinoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	bronchoalveolar adenocarcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	gastric cancer	Dihydrofolate reductase inhibitor	2.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	adult acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	lymphoid neoplasm	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	non-Hodgkins lymphoma	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	hepatosplenic T-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	mixed phenotype acute leukemia	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	head and neck squamous cell carcinoma	Dihydrofolate reductase inhibitor	1.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	breast neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PRALATREXATE	Small molecule	unspecified peripheral T-cell lymphoma	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	carcinoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	adenoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
METHOTREXATE	Small molecule	psoriasis vulgaris	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	atypical teratoid rhabdoid tumor	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Burkitts lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	sarcoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	upper aerodigestive tract neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute graft vs. host disease	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	urticaria	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	fallopian tube cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	neoplasm of mature B-cells	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	multiple myeloma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	primary peritoneal carcinoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	osteosarcoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	ovarian carcinoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	peritoneum cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	1.0	Withdrawn	ClinicalTrials
METHOTREXATE	Small molecule	uveitis	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	3.0	Suspended	ClinicalTrials
METHOTREXATE	Small molecule	diffuse large B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	anaplastic large cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	urothelial carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	ovarian cancer	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	Shwachman-Diamond syndrome	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute megakaryoblastic leukaemia	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	juvenile dermatomyositis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	ankylosing spondylitis	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	breast cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	beta-thalassemia major	Dihydrofolate reductase inhibitor	4.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	severe congenital neutropenia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute leukemia of ambiguous lineage	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	malaria	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	pancreatic carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	pancreatic carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	acute graft vs. host disease	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	graft versus host disease	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	central nervous system non-hodgkin lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	4.0	-	ATC
METHOTREXATE	Small molecule	osteosarcoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	cancer	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	large cell lung carcinoma	Dihydrofolate reductase inhibitor	4.0	-	DailyMed
PEMETREXED	Small molecule	leptomeningeal metastasis	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Graves ophthalmopathy	Dihydrofolate reductase inhibitor	4.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastatic colorectal cancer	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	chordoma	Dihydrofolate reductase inhibitor	1.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	primitive neuroectodermal tumor	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastasis	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	macular retinal edema	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	myelodysplastic syndrome	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	T-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	lymphoid leukemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	T-lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Churg-Strauss syndrome	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	T-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	2.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	rheumatoid arthritis	Dihydrofolate reductase inhibitor	4.0	Not yet recruiting	ClinicalTrials
METHOTREXATE	Small molecule	juvenile idiopathic arthritis	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Aplastic anemia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	nodal marginal zone B-cell lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	high grade B-cell lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	acute promyelocytic leukemia	Dihydrofolate reductase inhibitor	4.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	leukemia	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoblastic lymphoma	Dihydrofolate reductase inhibitor	3.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	paroxysmal nocturnal hemoglobinuria	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	B-cell acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	systemic scleroderma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	intermediate uveitis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	uveitis	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	metastatic colorectal cancer	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Dihydrofolate reductase inhibitor	1.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	large cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	3.0	Unknown status	ClinicalTrials
METHOTREXATE	Small molecule	mycosis fungoides	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	congenital amegakaryocytic thrombocytopenia	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Hodgkins lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Mantle cell lymphoma	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	psoriasis	Dihydrofolate reductase inhibitor	4.0	Active, not recruiting	ClinicalTrials
METHOTREXATE	Small molecule	HIV infection	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloblastic leukemia without maturation	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urogenital neoplasm	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	Hydatidiform Mole	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	gestational trophoblastic neoplasm	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	pancreatic neoplasm	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	non-Hodgkins lymphoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	acute myeloid leukemia	Dihydrofolate reductase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	squamous cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	large cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	Granulomatosis with Polyangiitis	Dihydrofolate reductase inhibitor	3.0	Terminated	ClinicalTrials
METHOTREXATE	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	Dihydrofolate reductase inhibitor	2.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	dermatomyositis	Dihydrofolate reductase inhibitor	3.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	lymphoma	Dihydrofolate reductase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Dihydrofolate reductase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Dihydrofolate reductase inhibitor	2.0	Completed	ClinicalTrials
METHOTREXATE	Small molecule	relapsing-remitting multiple sclerosis	Dihydrofolate reductase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-Hodgkins lymphoma	Dihydrofolate reductase inhibitor	1.0	Recruiting	ClinicalTrials
METHOTREXATE	Small molecule	adult acute lymphoblastic leukemia	Dihydrofolate reductase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	gestational trophoblastic neoplasm	Dihydrofolate reductase inhibitor	2.0	Terminated	ClinicalTrials

Welcome to

RBP World!

Drugs target to DHFR

Targets details